American Epilepsy Society Annual Meeting 2018

The American Epilepsy Society's (AES) 72nd Annual Meeting convened on November 30 to December 4, 2018. At the meeting, AES promotes both basic and clinical research at the vanguard of diagnosing, treating, and curing epilepsy offering high-quality educational content across diverse work settings, professional roles, and experience levels.
The director of the epilepsy center at Cleveland Clinic spoke about the process that leads to the selection of candidacy for deep brain stimulation.  
The pediatric psychologist at Children’s Medical Center discussed what her team does to assess patients in the clinic when something comes up as a result of a patient’s screening.
The Director of the Epilepsy Division at Mayo Clinic in Phoenix discussed the issue of driving when withdrawing patients off seizure medication either because of treatment, remission or surgical intervention.
The section chief of pediatric neurology at Nationwide Children’s Hospital discussed cannabidiol's potential in the Lennox-Gastaut syndrome space.
The Director of the Stanford Epilepsy Center discussed the work that’s left to be done in the field of epilepsy.
The instructor in neurology at Beth Israel Deaconess Medical Center spoke about what clinicians can do right now to mitigate the risk of SUDEP and the myriad of options for them to utilize.
The SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
The Director of the UCLA Seizure Disorder Center explained the importance of referring patients with seizures to epilepsy centers.
The Director of the Stanford Epilepsy Center discussed the current activities of epileptologists and considered how this might change in the near future, given advancing technology.
The associate professor of neurology at the University of Rochester shared some of her advice for treating patients with epilepsy and focusing on the patient.
The section chief of pediatric neurology at Nationwide Children’s Hospital and an associate professor of clinical pediatrics and neurology at The Ohio State University College of Medicine spoke about what the findings mean for patients.